62 related articles for article (PubMed ID: 14653352)
1. Bayesian techniques for sample size determination in clinical trials: a short review.
Pezeshk H
Stat Methods Med Res; 2003 Dec; 12(6):489-504. PubMed ID: 14653352
[TBL] [Abstract][Full Text] [Related]
2. Determination of the optimal sample size for a clinical trial accounting for the population size.
Stallard N; Miller F; Day S; Hee SW; Madan J; Zohar S; Posch M
Biom J; 2017 Jul; 59(4):609-625. PubMed ID: 27184938
[TBL] [Abstract][Full Text] [Related]
3. Sufficient trial size to inform clinical practice.
Manski CF; Tetenov A
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10518-23. PubMed ID: 27601679
[TBL] [Abstract][Full Text] [Related]
4. Decision-theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta-binomial distribution.
Hee SW; Parsons N; Stallard N
Biom J; 2018 Mar; 60(2):232-245. PubMed ID: 28744892
[TBL] [Abstract][Full Text] [Related]
5. Minimum sample size for estimating the Net Promoter Score under a Bayesian approach.
Costa EG; Ponte RTQ
An Acad Bras Cienc; 2024; 96(2):e20230991. PubMed ID: 38808878
[TBL] [Abstract][Full Text] [Related]
6. Robust time selection for interim analysis in the Bayesian phase 2 exploratory clinical trial.
Feng B; Zee B
J Biopharm Stat; 2024 May; 34(3):413-423. PubMed ID: 37144549
[TBL] [Abstract][Full Text] [Related]
7. Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.
Schlesselman JJ
J R Soc Med; 2016 Jan; 109(1):27-35. PubMed ID: 26801994
[No Abstract] [Full Text] [Related]
8. On the distribution of the power function for the scale parameter of exponential families.
De Santis F; Gubbiotti S
Stat Med; 2024 May; 43(10):1973-1992. PubMed ID: 38634314
[TBL] [Abstract][Full Text] [Related]
9. Discussion on "Bayesian meta-analysis of penetrance for cancer risk" by Thanthirige Lakshika M. Ruberu, Danielle Braun, Giovanni Parmigiani, and Swati Biswas.
Müller P; Flores B
Biometrics; 2024 Mar; 80(2):. PubMed ID: 38819313
[TBL] [Abstract][Full Text] [Related]
10. Statistical inference for agreement between multiple raters on a binary scale.
Vanbelle S
Br J Math Stat Psychol; 2024 May; 77(2):245-260. PubMed ID: 38233946
[TBL] [Abstract][Full Text] [Related]
11. A Bayesian predictive approach for dealing with pseudoreplication.
Lazic SE; Mellor JR; Ashby MC; Munafo MR
Sci Rep; 2020 Feb; 10(1):2366. PubMed ID: 32047274
[TBL] [Abstract][Full Text] [Related]
12. Bayesian sample size determination for coefficient of variation of normal distribution.
Ali S; Waheed M; Shah I; Raza SMM
J Appl Stat; 2024; 51(7):1271-1286. PubMed ID: 38835829
[TBL] [Abstract][Full Text] [Related]
13. Bayesian approach for sample size determination, illustrated with Soil Health Card data of Andhra Pradesh (India).
Brus DJ; Kempen B; Rossiter D; Balwinder-Singh ; McDonald AJ
Geoderma; 2022 Jan; 405():115396. PubMed ID: 34980929
[TBL] [Abstract][Full Text] [Related]
14. Combining Model-Based Clinical Trial Simulation, Pharmacoeconomics, and Value of Information to Optimize Trial Design.
Hill-McManus D; Hughes DA
CPT Pharmacometrics Syst Pharmacol; 2021 Jan; 10(1):75-83. PubMed ID: 33314752
[TBL] [Abstract][Full Text] [Related]
15. Principles of Good Clinical Trial Design.
An MW; Duong Q; Le-Rademacher J; Mandrekar SJ
J Thorac Oncol; 2020 Aug; 15(8):1277-1280. PubMed ID: 32417343
[TBL] [Abstract][Full Text] [Related]
16. Bayes factors for superiority, non-inferiority, and equivalence designs.
van Ravenzwaaij D; Monden R; Tendeiro JN; Ioannidis JPA
BMC Med Res Methodol; 2019 Mar; 19(1):71. PubMed ID: 30925900
[TBL] [Abstract][Full Text] [Related]
17. DELTA
Cook JA; Julious SA; Sones W; Hampson LV; Hewitt C; Berlin JA; Ashby D; Emsley R; Fergusson DA; Walters SJ; Wilson ECF; MacLennan G; Stallard N; Rothwell JC; Bland M; Brown L; Ramsay CR; Cook A; Armstrong D; Altman D; Vale LD
BMJ; 2018 Nov; 363():k3750. PubMed ID: 30560792
[TBL] [Abstract][Full Text] [Related]
18. DELTA
Cook JA; Julious SA; Sones W; Hampson LV; Hewitt C; Berlin JA; Ashby D; Emsley R; Fergusson DA; Walters SJ; Wilson ECF; Maclennan G; Stallard N; Rothwell JC; Bland M; Brown L; Ramsay CR; Cook A; Armstrong D; Altman D; Vale LD
Trials; 2018 Nov; 19(1):606. PubMed ID: 30400926
[TBL] [Abstract][Full Text] [Related]
19. Choosing the target difference ('effect size') for a randomised controlled trial - DELTA
Cook JA; Julious SA; Sones W; Rothwell JC; Ramsay CR; Hampson LV; Emsley R; Walters SJ; Hewitt C; Bland M; Fergusson DA; Berlin JA; Altman D; Vale LD
Trials; 2017 Jun; 18(1):271. PubMed ID: 28606102
[TBL] [Abstract][Full Text] [Related]
20. Sample size and classification error for Bayesian change-point models with unlabelled sub-groups and incomplete follow-up.
White SR; Muniz-Terrera G; Matthews FE
Stat Methods Med Res; 2018 May; 27(5):1476-1497. PubMed ID: 27507286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
